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Abstract 
In multiple sclerosis (MS), microstructural damage of normal-appearing brain tissue is an 
important feature of its pathology. Understanding these mechanisms is vital to help develop 
neuroprotective strategies. The visual pathway is a key model to study mechanisms of 
damage and recovery in demyelination. Anterograde trans-synaptic degeneration across the 
lateral geniculate nuclei has been suggested as a mechanism of tissue damage to explain optic 
radiation (OR) abnormalities seen in association with demyelinating disease and optic 
neuritis (ON), although evidence for this has relied solely on cross-sectional studies.  
 
We therefore aimed to assess 1) longitudinal changes in the diffusion properties of ORs after 
ON suggesting trans-synaptic degeneration; 2) the predictive value of early optic nerve MRI 
measures for late ORs changes; 3) the impact on visual outcome of both optic nerve and brain 
post-ON changes.  
 
Twenty-eight consecutive patients with acute ON and eight healthy controls were assessed 
visually (logMAR, colour vision, and Sloan 1.25%, 5%, 25%) and by MRI, at baseline, three, 
six, and twelve months. MRI sequences performed (and metrics obtained) were: i) Optic 
nerve fluid-attenuated inversion-recovery (optic nerve cross-sectional area); ii) Optic nerve 
proton density (PD) fast spin-echo (optic nerve PD-lesion length); iii) Optic nerve post-
gadolinium T1-weighted (gadolinium-enhanced lesion length); and iv) Brain diffusion-
weighted imaging (to derive OR fractional anisotropy [FA], radial diffusivity [RD], and axial 
diffusivity [AD]). Mixed-effects and multivariate regression models were performed, 
adjusting for age, gender, and OR lesion load. These identified changes over time and 
associations between early optic nerve measures and one-year global OR/clinical measures.  
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The FA in patients’ ORs decreased (p=0.018) and RD increased (p=0.002) over one year 
following ON, whereas OR measures were unchanged in controls. Also, smaller cross-
sectional areas of affected optic nerves at three months post-ON predicted lower FA and 
higher RD at one year (p=0.007) in the ORs, whereas none of the inflammatory measures of 
the optic nerve predicted changes in ORs. Finally, greater gadolinium-enhanced lesion length 
at baseline and greater optic nerve PD-lesion length at one year were associated with worse 
visual function at one year (p=0.034 for both). Neither the cross-sectional area of the affected 
optic nerve after ON nor the damage in ORs was associated with one-year visual outcome.  
 
Our longitudinal study shows that, after ON, there is progressive damage to the ORs, greater 
in patients with early residual optic nerve atrophy, even after adjusting for OR lesions. These 
findings provide evidence for trans-synaptic degeneration. 
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Introduction 
Disability accumulation in multiple sclerosis (MS) is thought to arise from both 
microstructural normal-appearing central nervous tissue damage and visible inflammatory 
changes (Fernando et al., 2005). A detailed understanding of the damage mechanisms in MS 
is crucial to help the development of biomarkers of tissue degeneration, which could be used 
in clinical trials to monitor neuroprotective treatment effects. The visual pathway, from the 
optic nerve to the visual cortex, and including the optic tracts, lateral geniculate nuclei and 
optic radiations, provides a well-characterised neural system and unique setting to study these 
mechanisms in vivo (Toosy et al., 2014).  
 
Inflammatory, demyelinating optic neuritis (ON) typically presents with the triad of 
dyschromatopsia, visual loss and painful eye movements. ON can be used as a model for 
relapse in multiple sclerosis (MS) to explore the mechanisms of damage, recovery and 
persistent deficits (Toosy et al., 2014). The acute ON lesion begins with focal inflammatory 
demyelination, giving rise to conduction block and loss of vision. Recovery of vision is 
associated with resolution of inflammation, oedema, remyelination (incomplete) and 
redistribution of sodium channels (Smith and McDonald, 1999). In the post-acute phase there 
may be persistent neuroaxonal loss and optic nerve atrophy (Hickman et al., 2002; Hickman 
et al., 2004; Jenkins et al., 2011).  
 
There is accumulating evidence from MRI studies for changes in post-geniculate visual 
pathways in association with ON. For example structural (Audoin et al., 2006; Jenkins et al., 
2011) and functional (Toosy et al., 2005; Jenkins et al., 2010, 2010b) cortical changes have 
been described after ON. The optic radiations (ORs) have also been investigated using 
diffusion tensor imaging (DTI), which provides information about voxel-level microstructural 
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properties (Basser et al., 1994; Pierpaoli and Basser, 1996; Beaulieu, 2002). Cross-sectional 
studies of ORs following ON have demonstrated (i) reduced connectivity metrics in the ORs 
after ON compared with healthy controls (Ciccarelli et al., 2005), (ii) increased tissue damage 
in the ORs, reflected by decreased fractional anisotropy (FA) and axial diffusivity (AD), and 
increased radial diffusivity (RD), after ON, compared with healthy controls (Reich et al., 
2009; Kolbe et al., 2012; Balk et al., 2015) (iii)  that MS patients with smaller retinal nerve 
fibre layer (RNFL) thickness had greater damage in the ORs as shown by lower FA and 
greater RD, suggestive of trans-synaptic degeneration (Reich et al., 2009); (iv) that MS 
patients with ON have more OR abnormalities than MS patients without a history of ON 
(Rocca et al., 2013; Gabilondo et al., 2014). These findings could be interpreted as reflecting 
a trans-synaptic degenerative process, where impaired synaptic input to lateral geniculate 
nucleus (LGN) neurons leads to secondary pathology in the ORs, although the data collected 
(analyses performed) have been cross-sectional hence the inferences made have been indirect. 
 
In order to better assess trans-synaptic degeneration, a longitudinal analysis is required after 
an incident ON to track the OR changes over time. We therefore conducted a prospective 
study of a cohort of acute ON patients followed up over one year with MRI and addressed 
three aims: 1) To characterize the longitudinal diffusion properties in the ORs after acute ON 
over one year; 2) To determine whether earlier ON structure characteristics predicts later OR 
diffusion changes, suggestive of a trans-synaptic lag effect; 3) To investigate how ON and 
OR MRI metrics correlate with visual function one year after the ON. 
 
We hypothesized that changes in the diffusion properties of the ORs can be predicted by 
changes in earlier optic nerve structure and can relate to clinical measures of visual function. 
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Methods 
Subjects 
Subjects with their first episode of acute unilateral ON and no previous neurological history 
were consecutively recruited from Moorfields Eye Hospital. Healthy volunteers were also 
recruited. Participants whose scans showed incidental inflammatory lesions after recruitment 
were included. Assessments were performed for each subject at baseline (within one month 
of onset of ON), 3, 6 and 12 months later. All subjects underwent MRI; ON patients 
additionally had visual function assessments. Also, in ON patients, the presence of a second 
relapse suggestive of MS (but not the topography of the second relapse) during the 12-month 
follow-up was recorded. The local Ethics Committee approved the study and all subjects 
provided informed written consent. 
 
Visual function 
A retroilluminated Early Treatment Diabetic Retinopathy Study (ETDRS) Chart was used to 
measure best corrected visual acuity, recorded as the 4m logarithm of the minimum angle of 
resolution (logMAR). Poorer visual acuity is reflected by higher logMAR scores. When no 
letters could be correctly identified, a score of 1.7 was assigned. The Humphrey automated 
field analyser was used to assess visual fields using the 30-2 programme (Allergan-
Humphrey Inc., San Leandro, Ca., USA). The global visual field mean deviation (HMD) was 
calculated. More negative error scores indicate worse vision. Colour vision (CV) was 
measured using the Farnsworth-Munsell 100-hue test (Farnsworth, 1943), and scored as the 
square root of the error score. If the visual acuity was too poor to attempt the test, an error 
score of 36.6 was assigned (Optic Neuritis Study Group, 1991). Higher error scores indicate 
worse vision. Low contrast acuity was assessed using Sloan charts (Ferris et al., 1982), at 
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25%, 5% and 1.25% contrast. The scoring system was identical to standard logMAR scoring, 
with higher scores indicating worse vision (Optic Neuritis Study Group, 1991). 
 
MRI studies 
MRI data were acquired using a 1.5T GE Signa Echospeed MRI (Milwaukee, WI) scanner 
with maximum gradient strength of 33mTm-1. All individuals were scanned at baseline, three 
months, six months and at 12 months.  
 
The MRI protocol was the follow-up study of Jenkins et al (Jenkins et al., 2011), where 
baseline data were reported. For the present study, we processed the images corresponding to 
three-month, six-month, and 12-month follow-up time points. The protocol included:  
 
Optic nerve structural scans:  
1) Coronal-oblique proton density (PD) fast spin-echo sequence (repetition time [TR] = 
2300ms, echo time [TE] = 68ms, 2 excitations, echo train length = 8, matrix size = 512 × 
384, field of view [FOV] = 24 × 18cm, 16 contiguous 3mm slices).  
2) Coronal-oblique fluid-attenuated inversion-recovery (FLAIR) imaging (TR = 2500ms, TE 
= 12.7ms, inversion time [TI] = 995ms, 6 excitations, echo train length = 6, matrix size = 512 
× 384, FOV = 24 × 18cm, 16 contiguous 3mm slices).  
3) Post-triple-dose gadolinium-enhanced coronal-oblique fat-saturated T1-weighted spin-
echo was acquired (TR = 600ms, TE = 20ms, 1 excitation, matrix size = 256 × 192, FOV = 
24 × 18cm, 16 contiguous 3mm slices). 
 
Optic nerve images were processed to obtain: 
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1) Lesion length (only in patients, at all time points), by an experienced (and blinded) 
neuroradiologist (K.M.).  
2) Optic nerve cross-sectional area (all individuals, at all time points), from five contiguous 
slices anterior from the orbital apex (Hickman et al., 2001), using a semiautomated 
contouring technique (Plummer, 1992), by a blinded observer (T.J.), as a marker of optic 
nerve axonal loss (Trip et al., 2006).  
3) Gadolinium-enhanced lesion length (only in patients and only at baseline)  
 
Brain structural and functional scans:  
1) Visual fMRI task-dependent scans acquired in four scanning sessions, as previously 
described (Jenkins et al., 2010).  
2) Diffusion-weighted imaging scans of the optic radiations and occipital lobes. We used an 
optimized single-shot, cardiac-gated, diffusion-weighted echo-planar imaging sequence, as 
previously described (Jenkins et al., 2010, 2010b, 2011). Diffusion-weighting gradients were 
applied along 61 distributed directions (Cook et al., 2007), with b = 1200sec/mm2, which was 
optimized for white matter. Seven interleaved non-diffusion-weighted b0 scans were also 
acquired. One additional b0 volume was acquired, covering the whole brain to assist co-
registration of partial brain diffusion data to whole-brain fMRI data (see below), which was 
necessary for tractography. Head motion– and eddy-current–induced distortions were 
corrected and the diffusion tensor was then calculated on a pixel-by-pixel basis, using FSL 
tools (http://www.fmrib.ox.ac.uk/fsl). 
3) Axial oblique, proton-density (PD), dual echo, fast spin echo of the whole brain, as 
previously described (Jenkins et al., 2010).  
 
Processing of OR images was as follows:  
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1) Diffusion-weighted images: the ORs were reconstructed using the FSL probabilistic 
tractography algorithm (http://www.fmrib.ox.ac.uk/fsl/fdt/fdt_probtrackx.html). First level 
fMRI contrast images for all subjects were combined and two spherical regions of interest 
(ROIs) of 3.5mm radius were created centred on the global maximal coordinates for each 
LGN (MNI coordinates: right 22 -24 -4 left -22-26 -4). ROIs underwent normalisation to 
each subject’s native space, co-registration to each subject’s partial brain diffusion data, via 
the whole brain b0 intermediate step, and binarisation. These ROIs were then moved in each 
subject’s native diffusion space to sit 8-10 voxels laterally within the apex of Meyer’s loops. 
Visual confirmation that they were placed correctly was performed in each case and 
probabilistic tractography was performed from these seed points (Jenkins et al., 2010). The 
reason why fMRI seeds were averaged at the group level was that signal at the individual 
level was considered too variable, and tractography results would have been unreliable. The 
mean fractional anisotropy (FA), axial and radial diffusivities (AD and RD) within the 
tractography-derived tract were obtained for each side, in each subject, at each time-point. 
Since optic nerve fibres approximately hemi-decussate at the optic chiasm, DTI metrics for 
left and right OR sides were averaged, after checking there were no significant differences 
between right and left hemispheres (data not shown). 
2) PD images: we used these images to obtain the whole brain and OR lesion load.  
3) Visual fMRI task-dependent scans were used to define the seed points needed for 
tractography of the ORs.  
 
Statistical analysis 
There were three stages of analysis: 
(1) Evaluation of differences between patients and controls in optic radiations’ DTI and optic 
nerve measures, at baseline and over time:  
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Differences at baseline: these were examined using multiple linear regression of the DTI or 
optic nerve variables as response variables, with a group indicator, age, and gender as 
covariates.  
 
Longitudinal differences over time: changes over time were examined with the measures of 
interest as response variables in linear mixed models with group, time and group x time 
interaction as explanatory variables, and with age and gender covariates. The possibility of 
non-linear trajectories was examined by including a quadratic term in time with 
corresponding group interaction. For changes in length of optic nerve lesion, OR lesion load 
at baseline was added as covariate.  
 
(2) Analysis of the relationship between early optic nerve variables and later OR variables.   
Multivariate multiple regression was used to simultaneously regress those OR DTI variables 
that had shown change over time on baseline optic nerve area of affected eye, PD-lesion 
length or gadolinium-enhanced lesion length, entered singly, with age, gender, baseline DTI 
and OR lesion load as covariates. Models with baseline optic nerve area as explanatory 
variable were also adjusted for optic nerve area of the unaffected eye. Unless otherwise 
stated, all results refer to models adjusted for these covariates. Two advantages of the 
multivariate regression were i) the possibility of a single joint test for an optic nerve predictor 
to reduce multiple testing: only a significant single joint test, with associations all in the same 
direction, was taken as evidence that the optic nerve predictor was associated with overall 
damage to the OR measures. ii) Under missing-at-random (MAR) and multivariate normality 
assumptions, all available data points contributed to the model to reduce the potential bias 
from exclusion of patients without complete data on all variables.  
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Similar multivariate models were fitted for individual optic nerve variables measured at three 
and six months after the optic neuritis (also adjusting for age, gender, OR lesion load at three 
or six months, respectively, and clinical variables also at three or six months) to determine 
temporal associations with OR DTI variables at one year. 
 
(3) To investigate how optic nerve and OR MRI metrics correlate with visual function, we 
performed two types of analyses, to assess:  
i) The relationship between early optic nerve variables and visual function one year after the 
optic neuritis. Multivariate regression models similar to those described above (2) were fitted. 
All one-year visual measures (i.e. LogMAR, Humphrey, Colour vision, Sloan charts at 
1.25%, 5%, and 25%) were response variables in simultaneously fitted regression models 
with baseline optic nerve explanatory variables entered singly; and with the following 
covariates: age, gender, baseline OR lesion load, and baseline values of the visual response 
variable. Unless otherwise stated, all results refer to models adjusted for these covariates. 
Joint tests similar to those in (2) were performed to reduce multiple testing. Similar models 
were fitted for optic nerve explanatory variables measured at three and six months after the 
optic neuritis. For these models, age, gender, OR lesion load at three or six months 
respectively, depending on the model, and visual response variables at three or six months 
were used as covariates.   
 
ii) Cross-sectional associations between optic nerve, optic radiation and visual function 
variables at one year. Multivariate regression models (again similar to those described 
above) were fitted. All one-year visual measures (i.e. LogMAR, Humphrey, Colour vision, 
Sloan charts at 1.25%, 5%, and 25%) were response variables in simultaneous regressions 
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with one-year optic nerve and OR variables entered singly as explanatory variables. Models 
were adjusted for age and gender. OR lesion load at one year and visual function at baseline 
were explored as covariates. 
 
Statistical evidence was considered when p-value was < 0.05. Statistical analysis was 
conducted using Stata 13.1 (Stata Corporation, College Station, Texas, USA). For the 
multivariate regressions the SEM (structural equation model) command was used with 
unstructured covariance and maximum likelihood with missing values.  
 
 
Results 
Twenty-eight ON patients (23 females) with mean (standard deviation (SD)) age of 32.04 
(6.53) years, and ten healthy controls (8 females) with mean (SD) age of 30.90 (3.11) years 
were recruited. Median duration from symptom onset was 22 days (range 7-34). Only 25 
patients (20 females) and 8 controls (6 females) had longitudinal data.  
 
1) Differences between patients and controls at baseline and over time 
 
After optic neuritis, the OR FA decreased and RD increased over one year. Patients’ 
affected optic nerve areas also decreased over time. 
 
Tables 1 and 2 show the main characteristics of optic radiations and optic nerve variables at 
baseline and at each time point, in patients and controls.  
 
i) Differences at baseline  
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There were no significant adjusted differences between patients’ and controls’ mean FA, RD, 
and AD in ORs: adjusted differences, i.e. patients’ minus controls’ measures, (95% CI) were: 
for FA: 0.007 (-0.021, 0.036), p=0.595; RD: 0.141·10-4 mm2/s (-0.270·10-4, 0.552·10-4), 
p=0.488 for RD; and AD: 0.402·10-4 mm2/s (-9.492·10-4, 10.296·10-4), p=0.934. 
 
Patients’ affected optic nerve areas were larger than controls’ areas: adjusted difference (95% 
CI): 1.801mm2 (0.097, 3.505), p=0.039; patients’ unaffected optic nerve areas were slightly 
and non-significantly smaller than controls’ optic nerve areas by -0.488 mm2 (-2.192, 1.216), 
p=0.569; patients’ affected optic nerve areas were larger than patients’ unaffected nerve areas 
by 2.289 mm2 (1.060, 3.517), p<0.001.  
 
ii) Differences over time 
For the ORs, average FA significantly decreased in patients over time (monthly rate of 
change [95% CI]: -1.483·10-3 FA units/month [-2.714·10-3, -0.251·10-3], p=0.018), whereas 
no significant longitudinal change occurred in controls (0.278·10-3 [-1.457·10-3, 2.013·10-3], 
p=0.754), although patient vs. control rate difference did not reach statistical significance 
(p=0.105) (Figure 1A). Average RD significantly increased in patients (0.031·10-4 
mm2/s/month [0.012·10-4, 0.049·10-4], p=0.001), whereas no significant longitudinal change 
occurred in controls (-0.008·10-4 mm2/s/month [-0.035·10-4, 0.018·10-4], p=0.549). 
Additionally, for RD, the rate of change was significantly more positive in patients than in 
controls by 0.039·10-4 mm2/s/month (0.006·10-4, 0.071·10-4), p=0.019 (Figure 1B). There 
was no evidence of non-linear change over time for FA or RD. Finally, average AD in the 
OR did not significantly change in patients (0.014·10-4 mm2/s/month [-0.005·10-4, 0.034·10-
6], p=0.155) or in controls (-0.003·10-4 mm2/s/month [-0.033·10-4, 0.026·10-4], p=0.819) 
(Figure 1C). 
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In patients, lesion load in the ORs (sum of left and right ORs) significantly increased over 
time (4.060 mm3/month [1.566, 6.554], p=0.001). For that reason, similar longitudinal 
(mixed-effects) models were created but adjusting for lesion load at each time point, not just 
at baseline. The results were similar to those reported when adjusting for baseline OR lesion 
load (Supplementary table 1).  
 
There was evidence of a non-linear decrease over time in the affected optic nerve area, with 
the rate of change levelling off from 6 to 12 months (regression coefficients (RCs) [95% CI]: 
-0.563 mm2/month [-0.779, -0.348], p<0.001; and 0.026 mm2/month2 [0.009, 0.043], 
p=0.002) (Figure 2A). The unaffected optic nerve area in patients or optic nerve area of 
controls did not significantly change over time, either in a linear (RCs [95% CI]: 0.046 
mm2/month [-0.170, 0.261], p=0.678; and 0.084 mm2/month [-0.279, 0.446], p=0.651, 
respectively) or in a non-linear way (p=0.956 and p=0.905, respectively). Optic nerve PD-
lesion length significantly increased over time in patients (RC [95% CI]: 1.598 mm/month 
[0.795, 2.402], p<0.001) and there was evidence of a negative non-linear component (RC 
[95% CI]: -0.066 mm/month2 [-0.129, -0.002], p=0.042), i.e. the increase in change of lesion 
size slowed down towards the end of the follow-up (Figure 2B).  
 
Finally, as expected, in patients, all visual outcomes of the affected eye improved over time, 
most of them showed a non-linear profile: a rapid initial improvement was followed by a 
plateau (Supplementary table 2).  
 
During follow-up, 11 patients had a second relapse (9 women; mean age [SD]: 32.273 years 
[7.964]; median OR lesion load at baseline [range]: 102.8 mm3 [0 to 494.8]), whereas 13 
 17 
patients did not (11 women; mean age [SD]: 30.846 years [5.145]; median OR lesion load at 
baseline [range]: 0 mm3 [0 to 107.2]). In 4 patients, clinical follow-up information was not 
available. There were no differences in OR FA, RD, or AD, between those who presented a 
second MS relapse during the follow-up and those who remained as clinically isolated 
syndromes, either at baseline (p-values = 0.514 (FA), 0.093 (RD), and 0.883 (AD)) or at one-
year follow-up (p-values = 0.121 (FA), 0.148 (RD), 0.510 (AD)).  
 
2) Predicting late OR DTI metrics from earlier optic nerve measures 
 
Greater optic nerve atrophy three months after optic neuritis predicted lower OR FA and 
higher OR RD at one-year  
 
OR FA and RD were entered into the multivariate analysis but not OR AD as this did not 
show significant change over time. Smaller optic nerve area of the affected eye at three 
months predicted greater damage in the ORs at one year, i.e. lower FA (RC [95% CI]: 0.535 
FA units/mm2 of optic nerve area [0.207, 0.863], p=0.001) and greater RD (RC [95% CI]: -
0.401 mm2/s/mm2 of optic nerve area [-0.762, -0.039], p=0.030), after one year of having 
developed the ON (joint test p=0.0069).  
  
Although at six months of follow-up smaller optic nerve areas of the affected eye implied 
lower FA and greater RD at one-year follow-up, these associations were not significant (joint 
test p=0.5996). None of the inflammatory parameters of the optic nerve predicted damage in 
the optic radiations after one year of the ON. Table 3 shows the standardised regression 
coefficients obtained from multivariate analyses.  
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3) Prediction of twelve-month visual outcome 
 
Longer gadolinium-enhanced optic nerve lesion length at baseline predicted worse clinical 
outcome at one-year after optic neuritis  
 
Table 4 shows the clinical measures at all time points, in patients.  
 
i) Prediction of one-year visual function by earlier optic nerve variables  
A longer gadolinium-enhanced optic nerve lesion at baseline predicted worse overall clinical 
outcomes (for LogMAR, Humphrey, colour vision, Sloan charts at 1.25%, 5%, and 25%) at 
one-year follow-up (joint test p=0.0386). The standardised regression coefficients are shown 
in Table 5. Greater optic nerve PD-lesion length of the affected side at three and six months 
predicted worse clinical outcome (in LogMAR, Humphrey, colour vision, and Sloan charts at 
1.25%, 5%, and 25%) at one-year follow-up, after adjusting only for age and gender (joint 
test p=0.0005 and p=0.0292, respectively). However, these associations became non-
significant (joint test p=0.1591 and p=0.4042, respectively) after adjusting for clinical 
measures and OR lesion load at the time point of the predictor (see Table 5). Finally, for all 
these models, being female was associated with better visual function at one year (joint test 
p<0.001), and worse visual function at baseline did not predict worse overall visual function 
at one-year follow-up (joint test p=0.1921). Age was not associated with visual function at 
one-year follow-up (Supplementary table 3 shows the standardised regression coefficients 
for visual function at baseline, age and gender in models with only these predictors).  
 
ii) Associations between optic nerve, OR variables and visual outcomes one year after ON 
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At twelve months after ON, greater optic nerve PD-lesion lengths were associated with worse 
overall clinical outcome (p=0.0338). No OR DTI metric was significantly associated with 
visual outcome at one year (Table 6).  
 
 
Discussion 
In this longitudinal study, trans-synaptic degeneration occurring after an acute inflammatory 
insult was investigated by assessing microstructural changes in the ORs over one year 
following first episode acute ON. Our findings provide strong evidence of anterograde trans-
synaptic degeneration in the visual pathway after ON because a) OR FA and RD demonstrate 
longitudinal degenerative changes over 12 months, even after adjusting for OR lesion load, 
and b) after the acute optic nerve insult, smaller affected optic nerves at three months predict 
twelve month OR FA and RD in a manner consistent with a trans-synaptic lag effect, again 
after adjusting for OR lesion volume. We also found that better visual recovery after ON was 
associated with milder early inflammation of the optic nerve, whereas early optic nerve 
atrophy or greater OR damage were not associated with the extent of visual recovery. We will 
now discuss each of these findings and their implications in more detail.  
 
After ON, there is progressive damage to the ORs that is independent of visible 
inflammation  
 
This study shows that after ON there is progressive decrease in FA and increase in RD in the 
ORs that is independent of the presence of visible lesions in the same brain region.  
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FA reflects the degree of water diffusion anisotropy of a given tissue, that is, the degree of 
diffusion along the main direction of diffusion (Pierpaoli and Basser, 1996). In our study, a 
progressive decrease in OR FA implied that after the ON there was an increase in the ability 
of water molecules to diffuse in all spatial directions, instead of being restricted by the natural 
tissue boundaries such as axonal structures. This denotes progressive tissue damage in the 
ORs, as suggested by different ex-vivo studies, where reduced FA can be associated with 
both demyelination (Mottershead et al., 2003; van Hecke et al., 2009; Zollinger et al., 2011), 
and axonal loss (Renoux et al., 2006). These results were supported by the presence of a 
progressive increase in RD in ON patients, implying a gradual increase in the ability of water 
molecules to diffuse across axonal fibres, reflecting either demyelination (Klawiter et al., 
2011; Zollinger et al., 2011) or axonal damage (DeBoy et al., 2007; Klawiter et al., 2011). 
Previous studies have also reported increases in OR RD in demyelination/ON (Reich et al., 
2009; Li et al., 2011; Kolbe et al., 2012; Rocca et al., 2013). Of note, the estimated rates of 
change in diffusion properties of the ORs and the difference between patients and controls in 
these rates of change remained unaltered after adjusting for OR lesion load, making it very 
unlikely that OR lesions have a significant biological influence. Hence, our reported changes 
in OR FA and RD probably reflect true microstructural changes most likely due to 
anterograde trans-synaptic degeneration, which could be one of the pathological substrates of 
the damage in normal-appearing brain tissue, at very early stages of MS (Fernando et al., 
2005). In fact, although there may be an association between greater visible inflammation and 
more important damage in the normal-appearing brain tissue, this damage cannot only be 
explained by visible lesions, implying that other degenerative mechanisms are probably 
involved (Fernando et al., 2005). 
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Trans-synaptic degeneration has been proposed as a mechanism of axonal and neuronal 
damage in many diseases of the CNS, including MS (Rocca et al., 2013). It results from 
deafferentation across a synapse (Ghetti et al., 1972; Ghetti and Wisniewski, 1972), and 
histopathological studies have shown that after the damage (or destruction) of pre-synaptic 
neuron, both pre-synaptic axon terminal and post-synaptic dendrite are engulfed by astrocytes 
(Ghetti and Wisniewski, 1972). Following this, myelinated post-synaptic axons start to show 
Wallerian degeneration (Ghetti et al., 1972). The observed longitudinal changes in OR FA 
and RD in our ON patients are consistent with this mechanism.   
 
After ON we did not observe significant changes in OR AD over time. This is consistent with 
some previous studies (Li et al., 2011; Raz et al., 2015) but not others, which have reported 
increases in OR AD (Reich et al., 2009). Both increases (Reich et al., 2009; Zollinger et al., 
2011) and decreases (DeBoy et al., 2007; Kolbe et al., 2012) for AD in demyelination have 
been reported, hence an overall change in AD may reflect a balance between competing 
influences making pathological inferences difficult to interpret. Also, previous studies have 
tended to be cross-sectional, performed in patients with established MS and/or ON. As a 
result, OR AD measurements may have been influenced by other, more chronic factors 
related to the underlying disease that would not have had time to affect the measurements in 
our study of incident ON. Additionally, it should be noted that the diffusion tensor (DT) is an 
approximation of the complex microstructure determining MR signal in the presence of 
diffusion weighting. Therefore it is possible that the DT does not capture damage along and 
across the main fibres of the ORs because the same damage blurs the true directions of the 
fibres (Wheeler-Kingshott and Cercignani, 2009; Wheeler-Kingshott et al., 2012). Another 
explanation for the non-significant AD change in our study could be simply lack of power 
due to inadequate sample size or measurement noise. 
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Evidence of early optic nerve atrophy after ON predicts more marked diffusion changes 
in the ORs independent of visible inflammation 
 
The proposed trans-synaptic mechanism of brain damage after ON is reinforced by the 
finding, in patients, of an association between smaller optic nerve areas of affected eyes three 
months after ON, and greater damage in the ORs one year after the ON, reflected by a greater 
decrease in FA, and greater increase in RD. At baseline assessment, the affected optic nerve 
areas were significantly larger than the unaffected and controls’ ones, explained by acute 
optic nerve swelling secondary to inflammation. As inflammation subsides, the affected optic 
nerve areas experienced an initial reduction in size –that slowed down in later months– and 
by twelve months the affected optic nerve areas were smaller than the unaffected and control 
eyes, implying neuroaxonal loss or optic nerve atrophy (Trip et al., 2006). ON patients with 
greater optic nerve axonal loss at three months (relatively early after the acute insult) 
developed greater damage in the ORs at 12 months, supporting the presence of trans-synaptic 
degeneration. Importantly, these associations were present after adjusting for the OR lesion 
load, again suggesting a degree of independence between visible white matter inflammation 
and microstructural changes in the ORs after the ON.  
 
Damage in optic radiations after ON suggesting anterograde trans-synaptic degeneration has 
been described by some authors (Ciccarelli et al., 2005; Korsholm et al., 2007; Kolbe et al., 
2012), but not others. A recent cross-sectional study did not show any correlation between 
RNFL thickness and OR damage in a cohort of 17 ON patients (Raz et al., 2015). Notably, 
our longitudinal study conveys a temporal association between optic nerve and OR structure 
further supporting trans-synaptic degeneration. 
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Better visual recovery after ON correlates with milder early inflammation of the optic 
nerve 
  
Longer baseline gadolinium-enhanced lesion length was associated with poorer visual 
function at twelve months, adjusting for OR lesion volume, age, gender, and baseline visual 
scores. Also, longer optic nerve lesions (measured on proton density MRI) at three and six 
months also predicted worse overall clinical outcome at one year, although this became non-
significant when adjusting for visual scores and OR lesion load, at both three and six months. 
Finally, at one-year follow-up greater optic nerve PD-lesion length, probably reflecting 
greater local secondary degeneration, of either Wallerian or retrograde type, was associated 
with worse overall clinical outcome, after adjusting for age, gender, and OR lesion load. 
These results are consistent with previous studies and reflect that the immediate mechanism 
of visual impairment after an ON and its recovery are mainly related to local changes within 
the optic nerve, such as swelling, which may compress optic nerve axons (Hickman et al., 
2004). Thus, those patients with smaller PD-lesion lengths at one year also had better visual 
outcomes. Remarkably, those patients with smaller optic nerve areas at any time of the 
follow-up, though, did not have a worse visual outcome, in line with previous studies that 
suggested the presence of redundancy of tissue or remodelling of function within the optic 
nerve (Hickman et al., 2004). Of note, in a previous analysis of our data, when a more 
conventional regression-type statistical approach was conducted, we did not find a significant 
association between acute structural measures of the optic nerve and visual function at twelve 
months (Jenkins et al., 2010b). In the present study, we adopted a multivariate approach with 
a multiple imputation method to account for missing data. Although multivariate approaches 
are generally more conservative and only the most robust associations are detected, the fact 
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that they can also account for missing data can increase the power to detect significant 
associations (Abdel-Aziz et al., 2015). This probably explains the discrepancy between the 
two analyses.  
 
In our study, none of the OR metrics were significantly associated with visual outcomes at 
one year. Other authors have reported some correlations between OR changes and visual 
function after ON (Reich et al., 2009). However, these correlations had been observed in 
patients with established MS, probably reflecting a longstanding impact of OR damage on 
visual function (Reich et al., 2009). Instead, our study was carried out in a population 
selected for having recently suffered an acute ON as CIS, and therefore with practically no 
disease duration, meaning that a hypothetical impact of ORs on visual function might not 
have had enough time to develop. Besides, the results are not consistent across studies (Kolbe 
et al., 2012), and the role on visual function of post-geniculate nucleus damage following ON 
needs still to be confirmed.  
 
Neither poorer vision at baseline nor age predicted worse overall visual outcome at one year 
(as shown in supplementary table 3). Interestingly, males showed a clear poorer overall 
visual outcome at one-year follow-up, as previously described (Costello et al., 2012; Malik et 
al., 2014; Costello et al., 2015). However, further research is required to determine the causes 
of this gender difference.  
 
In our study, 11 patients converted to clinically definite MS during the follow-up, whereas 13 
patients did not. Remarkably, in spite of those who presented a second relapse having higher 
OR lesion loads at baseline than those who did not, the baseline values of the diffusion 
metrics in the ORs were very similar for the two groups. This not only suggests a relative 
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independence of visible inflammation and diffusivity metrics, but also reinforces the main 
message of our paper, where we show that over time there is a progressive damage in the 
ORs that seems to be independent of visible inflammation, and which seems to be reflecting a 
trans-synaptic degeneration.  
 
Although our study has a longitudinal design that allowed us to model the evolution of 
changes over time in the ORs and determine their associations with anterior visual pathway 
structure, there are additional points to consider. We did not apply lesion masks to the ORs 
when obtaining the OR diffusion metrics. Of note, when we designed this study, we thought 
that the assessment of the parts of the WM tracts where lesions were nested could also be of 
interest, since they could also provide important information on tissue microstructure. 
Additionally, even if we had masked the lesions, we would still not have been able to exclude 
the local effect of visible lesions on the optic radiations through Wallerian degeneration.  
 
However, in order to ensure that our results were not just driven by OR lesions, we adjusted 
for the OR lesion loads, as performed by other authors (Balk et al., 2015), at baseline and 
over the follow-up period. Both the change in OR diffusion metrics in ON patients over time 
and the association between smaller optic nerve at three months and greater OR damage at 
one-year follow-up remained significant. We also carried out post-hoc analyses in which we 
re-ran the models described in the first stage of our study but excluded patients with highest 
OR lesion loads. Namely, we re-ran these models excluding patients with OR lesion loads 
equal to or greater than 392 mL (90th percentile of OR lesion load at 12 months), and in a 
separate model excluding patients with OR lesion loads equal to or greater than 172 mL (75th 
percentile of OR lesion load at 12 months). In these two analyses, patients –unlike controls– 
again showed a significant decrease in FA and a significant increase in RD, as with the 
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original analysis of the whole cohort. In addition, neither the direction nor the magnitude of 
the regression coefficients for FA and RD changed substantially (data not shown). Similarly, 
when we re-ran the models of the second stage of our analysis using only these sub-samples 
with lower OR lesion loads, the results still remained significant, i.e. smaller optic nerve 
areas at three months significantly predicted lower OR FA and higher OR RD at one-year 
follow-up (data not shown).    
 
Besides, as other authors have also shown, in our study the proportion of the tract volume 
occupied by lesions was very small, i.e. less than 3%, meaning that the potential impact of 
these lesions on the diffusion measures was probably negligible. In fact, at baseline, where 
some of the ON patients already showed white matter lesions in the ORs, the values of OR 
FA, RD, and AD were very similar in patients and controls (none of the comparisons were 
statistically significant), again implying that the impact of lesions on the averaged OR 
diffusivity metrics was minimal. 
 
Finally, even if the results of the first stage of our analysis, i.e. the presence of changes in OR 
diffusion metrics over time after ON, could potentially have been influenced by OR lesional 
diffusivity or could have reflected a global progressive neurodegenerative phenomenon, the 
results of the second part of the analysis, i.e. smaller optic nerve areas predict worse OR FA 
and RD independently of OR lesion load, still provide robust longitudinal evidence for 
anterograde trans-synaptic degeneration. Of course, it may well be that newer diffusion 
related techniques such as Neurite Orientation Dispersion and Density Imaging (NODDI) 
(Zhang et al., 2012; Grussu et al., 2015) will provide better understanding of microstructural 
changes underlying brain damage. Future studies using this and other techniques highly 
sensitive to tissue microstructure, and focusing on not only the ORs but also on other white 
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matter tracts not related to visual system, could further improve our knowledge of trans-
synaptic degeneration.  
 
Furthermore, our multivariate analysis assumes that the directional characteristics of the 
dependent variables behave in a biologically congruent manner. This is likely to be 
appropriate for both the DTI metrics, where FA and RD are known to reflect two aspects of 
the same process, i.e. the diffusion of water molecules in a given tissue, and the clinical 
variables, which improved over time in a similar non-linear way (Supplementary table 2). 
This suggests that our (conservative) approach of considering as significant only those 
associations that showed a similar biological direction was appropriate. With this approach, 
the risk of type I error was smaller than adopting other statistical approaches, hence ensuring 
that only the most robust associations were reported.  
 
In conclusion, our study provides longitudinal evidence of damage occurring in the ORs 
following ON, which is independent of white matter inflammation and more pronounced in 
patients with signs of post-acute optic nerve atrophy. This is strongly supportive of 
anterograde trans-synaptic degeneration. The lack of association between OR structural 
metrics and visual outcomes implies that local optic nerve factors played a greater role in this 
cohort, and perhaps for this relationship our study was underpowered. Future studies could 
investigate the clinical consequences of the post-synaptic changes that occur after ON, and 
whether they are due to the accumulation of structural brain damage or whether they are 
better explained by a disruption of brain structural connectivity secondary to axonal damage. 
Also, future trials using neuroprotective agents could evaluate the downstream effects on OR 
structure and whether OR damage could be ameliorated by early intervention to prevent optic 
nerve atrophy. 
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Table 1. Optic radiation variables at all time points 
 Patients Controls 
 Baseline 
3 
months 
6 
months 
12 
months 
Baseline 
3 
months 
6 
months 
12 
months 
N scanned 28 24 22 20 10 (c) 8 8 8 
Average FA 
(a) 
Mean (SD) 
0.361 
(0.031) 
0.363 
(0.034) 
0.350  
(0.039) 
0.350  
(0.038) 
0.356 
(0.035) 
0.376 
(0.047) 
0.365 
(0.024) 
0.364 
(0.028) 
Average RD 
(a) [x10-4 
mm2·s-1] 
Mean (SD) 
6.104 
(0.495)  
6.167 
(0.573)  
6.192 
(0.522)  
6.476 
(0.569)  
6.003 
(0.340)  
5.695 
(0.504)  
5.879 
(0.279)  
5.814 
(0.355) 
Average AD 
(a) [x10-4 
mm2·s-1] 
Mean (SD)  
10.783   
(0.672)  
10.945 
(0.708)  
10.675 
(0.534)  
11.070 
(0.776)  
10.465    
(0.425)  
10.023 
(0.297)  
10.305 
(0.387)  
10.288 
(0.334) 
OR lesion 
load [mm3]  
Mean (SD)  
 
Median 
(range) (b) 
63.021    
(117.159);  
 
 
3.5 (from 
0 to 
494.8), 
N=28 
67.925    
(120.559); 
  
 
9.7 (from 
0 to 
376.1), 
N=24 
120.2    
(195.737); 
  
 
34.75 (from 
0 to 812.9),  
N=22 
131.52     
(200.417);  
 
 
43.05 (from 
0 to 796.1), 
N=20 
- - - - 
 
(a) Average values from left and right optic radiations; (b) Due to OR lesion load being very 
positively skewed, median (range) is reported instead of mean (SD); (c) Although all 10 
controls were scanned at baseline, OR data were only available in 8 of them (6 women, 2 
men). Abbreviations: AD: axial diffusivity; FA: fractional anisotropy; mL: millilitres; mm: 
millimetres; N: number of individuals; OR: optic radiation; RD: radial diffusivity; s: seconds; 
SD: standard deviation;  
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Table 2. Optic nerve variables at all time points in patients 
 Patients 
 Baseline 3 months 6 months 12 months 
N scanned 28 24 22 20 
Area of affected eye 
[mm2]  
Mean (SD) 
14.629 
(3.205)  
12.681 
(1.704)  
12.376 
(1.587) 
11.296 
(1.772) 
Area of unaffected 
eye [mm2] 
Mean (SD) 
12.340 
(1.275) 
12.705 
(1.911) 
12.594 
(1.841) 
12.882 
(1.492) 
Length of ON 
lesion [mm] 
Mean (SD) 
22.071 
(10.367) 
25.250 
(11.498) 
29.045 
(8.899) 
31.200 
(9.356) 
Length of Gd 
enhancement  [mm]  
Mean (SD) (a) 
23.538 
(13.327) 
- - - 
 
(a) The length of the gadolinium enhancement was only assessed at baseline. Abbreviations: 
N: number of individuals; ON: optic nerve; SD: standard deviation.  
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Table 3. Prediction of optic radiation damage at one-year follow-up with optic nerve 
measures at different time points  
 
 
Dependent variables 
Joint test p-
value FA  RD (mm
2/s) 
Optic nerve measure (a) 
Standardised regression coefficients 
(95% CI) from multivariate analyses 
Affected optic nerve area at baseline  
-0.081  
(-0.336, 0.174) 
-0.147  
(-0.513, 0.219) 
0.2569 
Affected optic nerve area at 3 months 
0.535  
(0.207, 0.863) 
-0.401  
(-0.762, -0.039) 
0.0069 (b) 
Affected optic nerve area at 6 months 
0.256  
(-0.268, 0.779) 
-0.347  
(-1.243, 0.549) 
0.5996 
Lesion length of affected optic nerve at baseline 
0.218  
(-0.077, 0.513) 
-0.469  
(-0.874, -0.063) 
0.1058 
Lesion length of affected optic nerve at 3 months  
-0.074  
(-0.327, 0.179) 
0.048  
(-0.288, 0.384) 
0.7985  
Lesion length of affected optic nerve at 6 months  
0.117  
(-0.128, 0.361) 
-0.096  
(-0.502, 0.310) 
0.5610 
Gd-enhanced lesion length of affected optic nerve at 
baseline  
0.161  
(-0.126, 0.449) 
-0.276  
(-0.663, 0.112) 
0.3860  
 
(a) The predictors (optic nerve measures) shown in the table were tested individually (one at 
a time), together with age, gender, and OR lesion load at corresponding time point, either 
baseline, three-month follow-up, or six-month follow-up; (b) This was the only significant 
result and the effect of the predictor (affected eye’s area at 3 months) had effects on the 
dependent variables that went in the same biological direction. Abbreviations: FA: fractional 
anisotropy; Gd: gadolinium; OR: optic radiation; RD: radial diffusivity; SE: standard error.  
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 Table 4. Clinical variables at all time points in patients  
 
Clinical 
variables 
Time point 
Baseline 3 months 6 months 12 months 
N=28 N=24 N=23 N=24 
Affected Unaffected Affected Unaffected Affected Unaffected Affected Unaffected 
LogMAR 
scores  
Mean (SD) 
0.719 
(0.694) 
-0.049 
(0.103) 
0.164 
(0.351) 
 
-0.032 
(0.136) 
0.109 
(0.252) 
-0.040 
(0.109) 
0.091 
(0.220) 
 
-0.051 
(0.078) 
Humphrey 
scores  
Mean (SD) 
-19.510 
(9.672) 
-6.096 
(1.561) 
-8.221 
(3.307) 
-5.007 
(1.750) 
-7.849 
(2.846) 
-5.001 
(1.380) 
-7.219 
(2.515) 
 
-5.110 
(1.285) 
Colour 
vision 
scores   
Mean (SD) 
24.354 
(9.914) 
10.361 
(2.852) 
15.071 
(6.206) 
10.750 
(2.763) 
14.743 
(5.893) 
10.865 
(3.137) 
14.221 
(4.549) 
 
11.617 
(2.459) 
Sloan chart 
at 1.25% 
scores   
Mean (SD) 
1.624 
(0.247) 
0.697 
(0.288) 
1.428 
(0.381) 
0.762 
(0.332) 
1.268 
(0.417) 
0.713 
(0.280) 
1.080 
(0.372) 
0.684 
(0.275) 
Sloan chart 
at 5% 
scores 
Mean (SD) 
1.297 
(0.520) 
0.364 
(0.324) 
0.767 
(0.441) 
0.374 
(0.305) 
0.632 
(0.392)  
0.317 
(0.192) 
0.605 
(0.332) 
0.333 
(0.212)  
Sloan chart 
at 25% 
scores  
Mean (SD)  
0.829 
(0.673) 
0.051 
(0.134) 
0.293 
(0.353) 
0.062 
(0.168) 
0.244 
(0.278) 
0.041 
(0.129) 
0.211 
(0.256) 
0.061 
(0.108) 
 
Abbreviations: SD: standard deviation. See main text for further explanations about visual 
function scores.  
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Table 5. Prediction of clinical outcomes at one-year follow-up with optic nerve measures 
at different time points  
 
 Dependent variables 
Joint 
test p-
value 
 LogMAR Humphrey 
Colour 
vision 
Sloan 
charts at 
1.25% 
Sloan 
charts at 
5% 
Sloan 
charts at 
25% 
Optic nerve 
measure (a) 
Standardised regression coefficients (95% CI) from multivariate analyses  
Affected 
optic nerve 
area at 
baseline  
-0.257  
(-0.655, 
0.140) 
0.039  
(-0.418,  
0.496)  
0.283  
(-0.052, 
0.617) 
0.136  
(-0.222, 
0.495)  
-0.122  
(-0.505, 
0.260) 
-0.186  
(-0.582, 
0.210) 
0.0095 
(b) 
Affected 
optic nerve 
area at 3 
months 
-0.230  
(-0.633, 
0.173) 
0.216 
(-0.107,  
0.539)  
-0.126  
(-0.334, 
0.083) 
0.174  
(-0.213, 
0.562) 
0.098 
(-0.308, 
0.504) 
-0.138 
(-0.545, 
0.269) 
0.0006 
(b) 
Affected 
optic nerve 
area at 6 
months 
-0.020 
(-0.193, 
0.152) 
0.343 
(0.013, 
0.674)  
-0.079 
(-0.362, 
0.205) 
0.136 
(-0.200, 
0.471) 
0.134 
(-0.184, 
0.452) 
 
0.042 
(-0.219, 
0.304) 
0.2280  
Lesion 
length of 
affected 
optic nerve 
at baseline 
-0.116 
(-0.506, 
0.274) 
-0.122 
(-0.557,  
0.312) 
0.268  
(-0.183, 
0.718)  
0.153  
(-0.160, 
0.466)  
0.185 
(-0.142, 
0.512) 
 
0.022 
(-0.341, 
0.386) 
 
0.0908  
Lesion 
length of 
affected 
optic nerve 
at 3 months  
-0.007 
(-0.342, 
0.329)  
-0.169 
(-0.489,  
0.152) 
0.032 
(-0.180, 
0.244) 
0.133  
(-0.188, 
0.454)  
0.242 
(-0.059, 
0.544) 
0.084  
(-0.253, 
0.421) 
0.1591  
Lesion 
length of 
affected 
optic nerve 
at 6 months  
-0.013 
(-0.135, 
0.109) 
 
-0.071  
(-0.311, 
0.169)  
0.128 
(-0.069, 
0.324) 
 
0.070  
(-0.187, 
0.327)  
0.089 
(-0.157, 
0.336)  
0.029 
(-0.169, 
0.227) 
0.4042  
Gd-
enhanced 
lesion 
length of 
affected 
optic nerve 
at baseline  
0.205 
(-0.152, 
0.562)  
-0.479  
(-0.857,  
-0.102) 
0.584  
(0.260, 
0.907)  
0.104  
(-0.217, 
0.425)  
0.164  
(-0.167, 
0.496) 
 
0.206  
(-0.138, 
0.551)  
0.0386 
(c) 
 
(a) The predictors (optic nerve measures) shown in the table were tested individually (one at 
a time), together with age, gender, and visual function and OR lesion load at the same time 
point of the main predictor (i.e. optic nerve measure), either baseline, three-month follow-up, 
or six-month follow-up; (b) Although the joint test shows a significant result (at 5% 
significance level, p<0.05), the regression coefficients go in different ‘biological’ directions, 
so we have not considered this as a significant result; (c) Here the joint test shows a 
significant result and the regression coefficients go in the same biological direction. 
Abbreviations: CI: confidence interval.  
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Table 6. Associations between optic nerve and optic radiations variables and visual 
function at one-year follow-up 
 
 Dependent variables 
Joint 
test p-
value 
 LogMAR Humphrey 
Colour 
vision 
Sloan 
charts at 
1.25% 
Sloan 
charts at 
5% 
Sloan 
charts at 
25% 
One-year 
measures (a) 
Standardised regression coefficients (95% CI) from multivariate analyses 
Affected 
optic nerve 
area  
-0.080  
(-0.718, 
0.559)  
-0.015  
(-0.662, 
0.632)  
0.154  
(-0.471, 
0.779)  
0.236   
(-0.342, 
0.815) 
0.194  
(-0.430, 
0.818)  
-0.014  
(-0.654, 
0.626)  
0.1410 
Lesion length 
of affected 
optic nerve  
0.0442  
(-0.343, 
0.432) 
-0.372  
(-0.739,  
-0.004)  
0.434  
(0.098, 
0.770)  
0.114  
(-0.237, 
0.464) 
0.140 
(-0.233, 
0.513) 
0.069  
(-0.310, 
0.448)  
0.0338 
(b) 
Average FA 
-0.281  
(-0.980, 
0.419) 
-0.111  
(-0.890, 
0.668)  
0.034  
(-0.992, 
1.060) 
-0.016  
(-0.729, 
0.698) 
-0.205 
(-0.857, 
0.448)  
-0.174 
(-0.856, 
0.508) 
0.1193 
Average RD 
0.101  
(-0.350, 
0.552) 
-0.291  
(-0.742, 
0.161) 
0.143 
(-0.407, 
0.694) 
-0.015 
(-0.449, 
0.418) 
0.023  
(-0.391, 
0.438) 
-0.023 
(-0.448, 
0.402) 
0.0004 
(c) 
Average AD 
0.181  
(-0.546, 
0.907) 
-0.373 
(-1.086, 
0.340) 
0.313 
(-0.494, 
1.119) 
-0.105  
(-0.711, 
0.502) 
-0.039  
(-0.638, 
0.560)  
0.012  
(-0.623, 
0.647) 
0.2043 
 
(a) The predictors (optic nerve measures) shown in the table were tested individually (one at 
a time), together with age, gender, and visual function and OR lesion load at the same time 
point of the main predictor (i.e. optic nerve measure), either baseline, three-month follow-up, 
or six-month follow-up; (b) Here, all the coefficients pointed at the same biological direction 
and the joint test showed significant result at 5% significance level; (c) Although the joint test 
showed a significant result, since the coefficients pointed at different biological directions, 
we ignored this result. Abbreviations: AD: axial diffusivity; CI: confidence interval; FA: 
fractional anisotropy; RD: radial diffusivity.    
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Figure Legends 
Figure 1. Changes over time in DTI measures in the optic radiations 
Evolution over time of the DTI measures in the optic radiations over one year, after adjusting 
for OR lesion load at baseline, in patients (grey) and controls (black). In A, FA 
(dimensionless units) significantly decreased over time in patients, whereas it did not change 
significantly in controls. In B, radial diffusivity (mm2s-1 x10-4) significantly increased in 
patients, whereas it did not significantly change in controls. In C, axial diffusivity (mm2s-1 
x10-4) did not significantly change in patients or controls.  
 
Figure 2. Evolution of optic nerve measures over time 
Figure 2A shows the evolution over time of optic nerve areas in patients and in controls. As 
can be seen, optic nerve areas of affected eyes in patients decreased over time in a non-linear 
manner. Optic nerve areas of unaffected eyes in patients were consistently smaller than those 
in controls, although the difference did not reach statistical significance. The monthly rates of 
change in optic nerve areas in controls and in patients’ unaffected eyes were not significantly 
different from zero. Figure 2B shows the evolution over time of optic nerve lesion length in 
patients. As can be seen, optic nerve lesion length increased over time in a non-linear manner 
so that there is a levelling off towards the end of follow-up. Abbreviations: SE: standard 
error. 
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